NutriStack
Losartan and Potassium, a conflict.
Losartan blocks angiotensin II type 1 receptors, reducing aldosterone secretion and thereby decreasing renal potassium excretion. Adding potassium supplementation on top of this potassium-retaining effect can cause hyperkalemia, a potentially life-threatening condition that can lead to cardiac arrhythmias, heart block, and cardiac arrest. The risk is highest in patients with renal impairment, diabetes, or those taking other potassium-sparing agents.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Pair type
- Conflict
- Evidence (highest tier)
- Strong
- Source citations
- 6 sources
- Stack Score effect
- −10 to your Stack Score (per scored conflict row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Conflict · Strong evidence
Conflict
What is happening. Losartan blocks angiotensin II type 1 receptors, reducing aldosterone secretion and thereby decreasing renal potassium excretion. Adding potassium supplementation on top of this potassium-retaining effect can cause hyperkalemia, a potentially life-threatening condition that can lead to cardiac arrhythmias, heart block, and cardiac arrest. The risk is highest in patients with renal impairment, diabetes, or those taking other potassium-sparing agents.
Mechanism. Losartan blocks angiotensin II AT1 receptors in the adrenal cortex, reducing aldosterone release. Since aldosterone drives potassium secretion via epithelial sodium channels (ENaC) and ROMK channels in the collecting duct, its suppression causes potassium retention. Exogenous potassium further increases serum levels, risking hyperkalemia.
Recommendation. Avoid potassium supplementation while taking losartan unless directed by your prescriber with regular lab monitoring. Do not use potassium-containing salt substitutes. Have serum potassium checked within 1-2 weeks of starting losartan and periodically thereafter. Seek immediate medical attention for muscle weakness, palpitations, or numbness.
Sources (6)
- Raebel MA et al. Hyperkalemia after initiating renin-angiotensin system blockade: The Stockholm Creatinine Measurements (SCREAM) project. J Am Heart Assoc. 2017;6(8):e005428. PMID 28778944
- Desai AS. Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit. Circulation. 2008;118(16):1609-1611. PMID 18824641
- Xie M, Tang T, Liang H. Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis. Clinical Cardiology. 2023. PMID 37432701
- Filippini T, Naska A, Kasdagli MI et al.. Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 2020. PMID 32500831
- Behers BJ, Behers BM, Stephenson-Moe CA et al.. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length. Nutrients. 2024. PMID 39519450
- D'Elia L, Cappuccio FP, Masulli M et al.. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies. Nutrients. 2023. PMID 36839211
Stack Score
How this pair moves the number.
Effect on the composite score
If both Losartan and Potassium are in the same stack, this pair applies −10 to your Stack Score (per scored conflict row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.